Whitney M. Burrows, MD

1984-1988           A.B., English, Magna cum laude, Honors in Creative Writing, Brown University, Providence, RI

1989-1993           M.D., New York University School of Medicine, New York, NY

1993-1994           Internship, General Surgery, The Mount Sinai School of Medicine, New York, NY

1994-1998           Residency, General Surgery, The Mount Sinai School of Medicine, New York, NY

1998-2000            Residency, Cardiothoracic Surgery, Washington University School of Medicine, Barnes-Jewish      Hospital, St. Louis, MO

2000-2001           Fellowship, General Thoracic Surgery, Mayo Clinic, Rochester, MN

Dr. Whitney Burrows received his medical degree from New York University Medical School. He completed his surgical residency at Mount Sinai School of Medicine in New York. Upon completion of his fellowship at Barnes Hospital-Washington University in St. Louis, Dr. Burrows spent a year at the Mayo Clinic in Rochester, Minnesota, advancing his training in general thoracic surgery. 

He holds the title of assistant professor of surgery at the University of Maryland School of Medicine.  In addition, he is a member of the University of Maryland Division of Thoracic Surgery and the Thoracic Oncology Program at the University of Maryland Greenebaum Comprehensive Cancer Center.

Esophageal Cancer, Lung Cancer, Mediastinal Tumors, Esophageal Disease (Benign), Lung Nodules, Diaphragmatic Hernia/Paraesophageal Hernia, Reflux, Malignant Pleural effusions , Pneumothorax, Emphysema, Hyperhidrosis

1. Krasna MJ, Jiao X, Mao YS, Sonett J, Gamliel Z, Kwong K, Burrows W, Flowers JL, Greenwald B, White C. Thoracoscopy/laparoscopy in the staging of esophageal cancer: Maryland experience. Surg Laparosc Endosc Percutan Tech. 2002, Aug;12(4):213-8. PubMed PMID: 12193812.
2. Jiao X, Eslami A, Ioffe O, Kwong KF, Henry M, Zeng Q, Refaely Y, Burrows W, Gamliel Z, Krasna MJ. Immunohistochemistry analysis of micrometastasis in pretreatment lymph nodes from patients with esophageal cancer. Ann Thorac Surg. 2003 Oct;76(4):996-9; discussion 999-1000. PubMed PMID: 14529974.
3. Burrows WM. Gastrointestinal function and related problems following esophagectomy.  Semin Thorac Cardiovasc Surg. 2004 Summer;16(2):142-51. Review. PubMed PMID: 15197689.
4. Kwong KF, Cooper LB, Bennett LA, Burrows W, Gamliel Z, Krasna MJ. Clinical experience in 397 consecutive thoracoscopic sympathectomies. Ann Thorac Surg. 2005 Sep;80(3):1063-6; discussion 1066. PubMed PMID: 16122487.
5. Kwong KF, Edelman MJ, Suntharalingam M, Cooper LB, Gamliel Z, Burrows W, Hausner P, Doyle LA, Krasna MJ. High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survival. J Thorac Cardiovasc Surg. 2005 Jun;129(6):1250-7.PubMed PMID: 15942564.
6. Burrows WM. Anatomical lung resection after neoadjuvant chemoradiotherapy.  Semin Thorac Cardiovasc Surg. 2007 Winter;19(4):360-5. doi:10.1053/j.semtcvs.2007.12.002. Review. PubMed PMID: 18395639.
7. Kwong KF, Hobbs JL, Cooper LB, Burrows W, Gamliel Z, Krasna MJ. Stratified analysis of clinical outcomes in thoracoscopic sympathicotomy for hyperhidrosis.  Ann Thorac Surg. 2008 Feb;85(2):390-3; discussion 393-4. doi:10.1016/j.athoracsur.2007.08.001. PubMed PMID: 18222231.
8. Holton LH 3rd, Chung T, Silverman RP, Haerian H, Goldberg NH, Burrows WM, Gobin A, Butler CE. Comparison of acellular dermal matrix and synthetic mesh for lateral chest wall reconstruction in a rabbit model. Plast Reconstr Surg. 2007 Apr 1;119(4):1238-46. PubMed PMID: 17496596.
9. Edelman MJ, Suntharalingam M, Burrows W, Kwong KF, Mitra N, Gamliel Z, Riley M, Cooper LB, Kennedy NL, Buskirk S, Hausner P, Doyle LA, Krasna MJ. Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancer. Ann Thorac Surg. 2008 Sep;86(3):903-10. doi:10.1016/j.athoracsur.2008.06.022. PubMed PMID: 18721580.
10. Krasna MJ, Gamliel Z, Burrows WM, Sonett JR, Kwong KF, Edelman MJ, Hausner PF, Doyle LA, DeYoung C, Suntharalingam M. Pneumonectomy for lung cancer after preoperative concurrent chemotherapy and high-dose radiation. Ann Thorac Surg. 2010 Jan;89(1):200-6; discussion 206. doi: 10.1016/j.athoracsur.2009.08.069. PubMed PMID: 20103235.
11. Edelman MJ, Burrows W, Krasna MJ, Bedor M, Smith R, Suntharalingam M. Phase I trial of carboplatin/paclitaxel/bortezomib and concurrent radiotherapy followed by surgical resection in Stage III non-small cell lung cancer. Lung Cancer. 2010 Apr;68(1):84-8. doi:10.1016/j.lungcan.2009.05.003. Epub 2009 Jun 21. PubMed PMID: 19540615.
12. Koshy M, Greenwald BD, Hausner P, Krasna MJ, Horiba N, Battafarano RJ, Burrows W, Suntharalingam M. Outcomes after trimodality therapy for esophageal cancer:the impact of histology on failure patterns. Am J Clin Oncol. 2011 Jun;34(3):259-64. doi: 10.1097/COC.0b013e3181e841ce. PubMed PMID: 20686405.
13. Suntharalingam M, Paulus R, Edelman MJ, Krasna M, Burrows W, Gore E, Wilson LD, Choy H. Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):456-63. doi: 10.1016/j.ijrobp.2011.11.069. Epub 2012 Apr 28. PubMed PMID:22543206.
14. Saxena H, Deshpande DA, Tiegs BC, Yan H, Battafarano RJ, Burrows WM, Damera G, Panettieri RA, Dubose TD Jr, An SS, Penn RB. The GPCR OGR1 (GPR68) mediates diverse signalling and contraction of airway smooth muscle in response to small reductions in extracellular pH. Br J Pharmacol. 2012 Jun;166(3):981-90. doi:10.1111/j.1476-5381.2011.01807.x. PubMed PMID: 22145625; PubMed Central PMCID:PMC3417423.
15. Dipetrillo T, Suntharalingam M, Ng T, Fontaine J, Horiba N, Oldenburg N, Perez K, Birnbaum A, Battafarano R, Burrows W, Safran H. Neoadjuvant paclitaxel poliglumex, cisplatin, and radiation for esophageal cancer: a phase 2 trial. Am J Clin Oncol. 2012 Feb;35(1):64-7. doi:10.1097/COC.0b013e318201a126. PubMed PMID:21297434.
16. Boggs DH, Tarabolous C, Morris CG, Hanna A, Burrows W, Horiba N, Suntharalingam M.  Analysis of pathological complete response rates with paclitaxel-based regimens in trimodality therapy for esophageal cancer. Dis Esophagus. 2014 May 26. doi: 10.1111/dote.12243. PMID:24863682
17. Boggs  DH,  Hanna A, Burrows W, Horiba N, Suntharalingam M. Primary Gross Tumor Volume is an Important Prognostic Factor in Locally Advanced Esophageal Cancer Patients Treated with Trimodality Therapy. J Gastrointest Cancer. 2015 Jun;46(2):131-7. doi:  10.1007/s12029-015-9699-y.  Pubmed PMID 25759174
18. Kim GJ, Koshy M, Hanlon AL, Horiba MN, Edelman MJ, Burrows WM, Battafarano RJ, Suntharalingam M. The Benefit of Chemotherapy in Esophageal Cancer Patients with Residual Disease After Trimodality Therapy. Am J Clin Oncol. 2016 Apr;39(2):136-41. PMID:24487417
19. Burrows W, Culligan M, Hesdorffer M, Friedberg JS. Conducting Surgery-based Clinical Trials for Malignant Pleural Mesothelioma; The Ethical, Scientific and Practical Challenges. Accepted for publication the International Journal of Clinical Research and Trials